CBCVCannabichromevarin
The propyl homologue of cannabichromene, isolated from Thai cannabis in 1975.
C₁₉H₂₆O₂
CAS 57130-04-8
- Family
- PhytocannabinoidMinor
- Origin
- Decarboxylation
- Molar mass
- 286.40 g/mol
Updated on
In plain terms
Cannabichromevarin is the "short" version of cannabichromene: its side chain has three carbons instead of five. Present in very small amounts in some varieties, it remains little studied; its effects in humans have not been studied in the sources consulted.
Receptors and activity
Measured effects
Not characterised. No placebo-controlled human trial has measured the effects of CBCV, so no level is shown.
Levels computed from placebo-controlled human trials: difference from placebo on 100, at the dose and route stated. Read the method
Pharmacology
Cannabichromevarin (CBCV) is the propyl-chain homologue of cannabichromene, isolated in 1975 by Shoyama and colleagues from the Thai cannabis "Meao variant", together with cannabigerovarin. It forms by decarboxylation of its acid, CBCVA; formation of that acid by CBCA synthase is presumed but not demonstrated. Its own pharmacology remains very poorly documented: no measured affinity for the CB1 or CB2 receptors has been published. In mice, CBCV was rapidly absorbed and penetrated the brain but, unlike CBC, CBCA and CBCVA tested under the same conditions, it did not raise the seizure threshold in a mouse model of Dravet syndrome (Anderson et al. 2021).
Key sources.
- Shoyama Y. et al. 1975, Chem Pharm Bull 23:1894-1895: cannabichromevarin and cannabigerovarin, two new propyl homologues (new tab)DOI 10.1248/cpb.23.1894
- Radwan M.M. et al. 2021, Molecules 26:2774: inventory of 125 cannabinoids (±CBCV and (+)-CBCV) (new tab)PMID 34066753
- Anderson L.L. et al. 2021, ACS Chem Neurosci 12:330-339: CBC, related phytocannabinoids and 5-fluoro-CBC in a mouse model of Dravet syndrome (new tab)PMID 33395525
- Brighenti V. et al. 2024, Anal Bioanal Chem 416:4555-4569: HPLC of impurities in natural and synthetic CBD (new tab)PMID 38940871
- ChEBI CHEBI:228766: cannabichromevarin (new tab)
History
- Source
- Cannabis sativa L.: present in the plant, formed by non-enzymatic decarboxylation of its acid, CBCVA. (+)-CBCV was isolated from a Thai "Meao variant" cannabis; a racemic (±) CBCV has also been identified by gas chromatography coupled with mass spectrometry (Radwan et al. 2021).
Biosynthetic pathway
CBCV belongs to the propyl-chain series, which starts from divarinolic acid instead of olivetolic acid: condensation with geranyl pyrophosphate gives cannabigerovarinic acid (CBGVA). Conversion of CBGVA into cannabichromevarinic acid (CBCVA) by CBCA synthase is presumed, by analogy with the pentyl series, but has not been demonstrated in the sources consulted. Decarboxylation of CBCVA, under heat or ageing, gives CBCV.
Legal framework
- European Union
Not listed by name in the schedules of the 1961 and 1971 United Nations conventions, according to annexes I to III of the ANSM consolidated list (26/06/2026). Checked on 20/10/2026.
- France
Not a controlled narcotic: CBCV is not named in the ANSM consolidated list (updated 26/06/2026) and, as a CBC-type molecule with a 2H-chromene nucleus, it does not belong to the generic class of benzo[c]chromene derivatives (ANSM decisions of 22/05/2024 and 03/06/2024). Checked on 20/10/2026.
Sources: EUR-Lex, UNODC, CND, ANSM, IUPHAR/BPS, ChEBI, EUDA. Our method.
Classification
Family, origin and source verification
- Family
Phytocannabinoid › Minor
- Presence in the plant
Neutral form: decarboxylation of a plant acid
- Chemistry
Type CBC · C3 side chain · neutral form
- Verification
Every fact on this entry was checked against its primary sources on 20 October 2026.
- Wikipedia (English)
Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.
References
- Shoyama Y. et al. 1975, Chem Pharm Bull 23:1894-1895: cannabichromevarin and cannabigerovarin, two new propyl homologues (new tab)DOI 10.1248/cpb.23.1894
- Radwan M.M. et al. 2021, Molecules 26:2774: inventory of 125 cannabinoids (±CBCV and (+)-CBCV) (new tab)PMID 34066753
- Anderson L.L. et al. 2021, ACS Chem Neurosci 12:330-339: CBC, related phytocannabinoids and 5-fluoro-CBC in a mouse model of Dravet syndrome (new tab)PMID 33395525
- Brighenti V. et al. 2024, Anal Bioanal Chem 416:4555-4569: HPLC of impurities in natural and synthetic CBD (new tab)PMID 38940871
- ChEBI CHEBI:228766: cannabichromevarin (new tab)
Identifiers
Names
- Common name
- Cannabichromevarin
- IUPAC name
- 2-methyl-2-(4-methylpent-3-enyl)-7-propylchromen-5-ol
- Other names
- CBCV · Cannabivarichromene
Identifiers
- Formula
- C₁₉H₂₆O₂
- CAS
- 57130-04-8
- PubChem CID
- 6451726(new tab)
- InChIKey
- AAXZFUQLLRMVOG-UHFFFAOYSA-N
- SMILES
- CCCC1=
CC(= C2C= CC(OC2= C1) (C) CCC= C(C) C) O
LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.